The accelerated Rett Syndrome Market growth is a direct result of several powerful, converging trends, most notably the transition from a market dominated by palliative care to one increasingly focused on disease-modifying treatments. The recent regulatory approval of the first-ever drug for Rett Syndrome, which demonstrated clinical benefits by improving core symptoms, has injected...